| __timestamp | CRISPR Therapeutics AG | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 1513000 | 9216000000 |
| Thursday, January 1, 2015 | 12573000 | 8296000000 |
| Friday, January 1, 2016 | 42238000 | 10044000000 |
| Sunday, January 1, 2017 | 69800000 | 11560000000 |
| Monday, January 1, 2018 | 113773000 | 10558000000 |
| Tuesday, January 1, 2019 | 179362000 | 9351000000 |
| Wednesday, January 1, 2020 | 269407000 | 8933000000 |
| Friday, January 1, 2021 | 17953000 | 8284000000 |
| Saturday, January 1, 2022 | 110250000 | 7952000000 |
| Sunday, January 1, 2023 | 130250000 | 8200000000 |
| Monday, January 1, 2024 | -2314000 | 8480000000 |
Unleashing insights
In the ever-evolving landscape of biotechnology, the cost of revenue is a critical metric that reflects a company's operational efficiency. This chart compares the cost of revenue for Teva Pharmaceutical Industries Limited and CRISPR Therapeutics AG from 2014 to 2023. Over this period, Teva consistently reported a significantly higher cost of revenue, peaking at approximately $11 billion in 2017. In contrast, CRISPR Therapeutics AG, a pioneer in gene-editing technology, showed a more modest increase, with its cost of revenue reaching around $130 million in 2023.
Teva's cost of revenue decreased by about 29% from its 2017 peak, indicating strategic cost management. Meanwhile, CRISPR's cost of revenue surged by over 8,500% from 2014 to 2023, reflecting its rapid growth and expansion in the biotech sector. This comparison highlights the diverse financial strategies and growth trajectories of these two industry leaders.
AbbVie Inc. vs Teva Pharmaceutical Industries Limited: Efficiency in Cost of Revenue Explored
Merck & Co., Inc. vs CRISPR Therapeutics AG: Efficiency in Cost of Revenue Explored
AstraZeneca PLC vs Teva Pharmaceutical Industries Limited: Efficiency in Cost of Revenue Explored
Amgen Inc. vs CRISPR Therapeutics AG: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: Gilead Sciences, Inc. vs CRISPR Therapeutics AG
Cost Insights: Breaking Down Vertex Pharmaceuticals Incorporated and Teva Pharmaceutical Industries Limited's Expenses
Cost Insights: Breaking Down Teva Pharmaceutical Industries Limited and Intra-Cellular Therapies, Inc.'s Expenses
Cost of Revenue: Key Insights for Teva Pharmaceutical Industries Limited and Halozyme Therapeutics, Inc.
Cost of Revenue Comparison: Teva Pharmaceutical Industries Limited vs Amneal Pharmaceuticals, Inc.
Cost of Revenue Comparison: Teva Pharmaceutical Industries Limited vs HUTCHMED (China) Limited
Analyzing Cost of Revenue: Teva Pharmaceutical Industries Limited and Dyne Therapeutics, Inc.